Th2 cell clonal expansion at diagnosis in human type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Th2 cell clonal expansion at diagnosis in human type 1 diabetes

Published:2023-12 Issue: Volume:257 Page:109829
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Narsale Aditi,Almanza Francisco,Tran Theo,Lam Breanna,Seo David,Vu Alisa,Long S. Alice,Cooney Laura,Serti Elisavet,Davies Joanna D.

Funder

Leona M. and Harry B. Helmsley Charitable Trust

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference78 articles.

1. Type 1 diabetes;Atkinson;Lancet (London, England),2014

2. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(ala-ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type I diabetes;Herold;Diabetes,2005

3. Insulin needs after CD3-antibody therapy in new-onset type I diabetes;Keymeulen;N. Engl. J. Med.,2005

4. Four-year metabolic outcome of a randomized controlled CD3-antibody trial in recent-onset type I diabetic patients depends on their age and baseline residual beta-cell mass;Keymeulen;Diabetologia,2010

5. Protégé trial investigators. Teplizumab for treatment of type I diabetes (Protégé study): 1-year results from a randomized, placebo-controlled trial;Sherry;Lancet,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus;Cytokine;2024-10

2. Type 1 diabetes: immune pathology and novel therapeutic approaches;Diabetology International;2024-09-11

3. Comment on Narsale et al. Th2 cell clonal expansion at diagnosis in human type 1 diabetes. Clin Immunol. 2023 Oct 29;Clinical Immunology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3